For cats, there is a safer vaccine: Purevax, by Merial, is
a recombinant vector vaccine that does not induce the inflammation that occurs with killed, adjuvanted vaccines.
Not exact matches
Many life - saving products, such as
recombinant therapeutic proteins,
vaccines, and gene therapy
vectors, are produced from large - scale cell culture systems.
The laboratory has also all of the technologies required to produce
recombinant bacteria expressing
vaccine antigens to be used as non-pathogenic
vaccine vectors.
In the health care industry, many life - saving products, such as
recombinant therapeutic proteins,
vaccines, and gene therapy
vectors, are produced from large - scale cell culture systems.
The Viral
Vector Core Facility produces
recombinant virus -
vectored vaccines for pre-clinical validation experiments and GMP starting material.
Moreover, UNISI produces
recombinant bacteria expressing
vaccine antigens to be used as non-pathogenic
vaccine vectors.
He receives research funding from the BBSRC to study host innate responses and
recombinant vaccine vectors.
RV 172: A Phase I / II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV - 1 DNA Plasmid
Vaccine, VRC - HIVDNA016 -00-VP, Boosted by a Multiclade HIV - 1
Recombinant ADENOVIRUS - 5
Vector Vaccine, VRC - HIVADV014 -00-VP in HIV Uninfected Adu
While the USDA recognizes four categories of
recombinant vaccines, only the «
Vectored Virus» Category is commercially available.
As an added benefit, PUREVAX
Recombinant Leukemia
vaccine employs canarypox -
vectored vaccine technology.
p. 3» When compared with infectious (attenuated, avirulent, modified live,
recombinant viral
vectored)
vaccines, noninfectious
vaccines are more likely to produce local and systemic adverse reactions in some dogs.»
p. 34» The vaccination protocol that includes the minimum number of
vaccines yet still provides a reasonable opportunity to immunize the dog would be: a single dose of combined infectious (attenuated, avirulent, modified live,
recombinant viral
vectored) CDV, MLV CPV - 2, with MLV CAV - 2, administered at 16 wk of age or older, plus a rabies shot at the same time (but inoculated at a separate site on the body).
Recombinant:
Vaccine manufactured through gene cloning (plasmid expressed) or by recombining selected DNA from a pathogenic organism with DNA from another virus (viral
vectored), leading to the expression, following inoculation, of only essential antigens required to immunize.
While the USDA recognizes four categories of
recombinant vaccines, only the
vectored virus category is commercially available.